trending Market Intelligence /marketintelligence/en/news-insights/trending/UPClIQx-yixNTfBOjkgxjQ2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Kee Song Bio-Technology Q1 profit climbs 27.4% YOY

PODCAST

Episode 5: The Future of Work - The World of Workforce Experience and Productivity

Blog

Needham & Company is Now Available in the S&P Global Market Intelligence Aftermarket Research Collection

Blog

The State of Green Business 2021: Positive Impact

Blog

European subscription OTT video 5-year outlook


Kee Song Bio-Technology Q1 profit climbs 27.4% YOY

Kee Song Bio-Technology Holdings Ltd said its first-quarter normalized net income came to 70 Taiwan cents per share, an increase of 27.4% from 55 cents per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was NT$23.9 million, an increase of 27.4% from NT$18.8 million in the year-earlier period.

The normalized profit margin climbed to 7.4% from 5.7% in the year-earlier period.

Total revenue fell on an annual basis to NT$324.2 million from NT$329.5 million, and total operating expenses decreased year over year to NT$291.6 million from NT$302.6 million.

Reported net income grew 23.2% from the prior-year period to NT$30.7 million, or 90 cents per share, from NT$24.9 million, or 73 cents per share.

As of May 14, US$1 was equivalent to NT$30.54.